July 8, 2019 by Jeffrey Woldt
Brian Tyler, John Hammergren, McKesson
July 8, 2019, News
IRVING, Texas — A week before he succeeded John Hammergren as chief executive officer of McKesson Corp., Brian Tyler wrote on the company’s website that he was getting ready for the job of a lifetime. Tyler might have added that, in light of the serious problems that continue to plague the health care system in
January 30, 2019 by Chain Drug Review
John Hammergren, McKesson Corp., US Oncology Research, World Cancer Day
Leading Headlines, Pharmacy
SAN FRANCISCO — McKesson Corp. is supporting World Cancer Day by expanding its commitment to reduce the devastating impact of cancer by making medicines and treatment readily available and by supporting those on the frontlines. “Most Americans have been touched by cancer. We know that better cancer care is possible and McKesson is proud to play a part in making that
December 3, 2018 by Chain Drug Review
Brian Tyler, John Hammergren, Las Colinas, McKesson Corp.
Business, Leading Headlines, Pharmacy
SAN FRANCISCO — McKesson Corp. has announced the relocation of its corporate headquarters from San Francisco, Calif. to Las Colinas, Texas, effective April 1, 2019, expanding upon its presence in the Dallas area. “We are excited to strengthen our presence in Texas and make Las Colinas our official global headquarters,” said John Hammergren, chairman and chief
November 1, 2018 by Chain Drug Review
Brian Tyler, Edward Mueller, John Hammergren, McKesson Corp.
Featured Articles, Leading Headlines, Pharmacy, Retail News
SAN FRANCISCO — McKesson Corp. announced that John Hammergren, chairman and chief executive officer, has decided to retire, effective March 31, 2019. McKesson’s board of directors has unanimously selected Brian Tyler, currently president and chief operating officer, to succeed Hammergren as CEO, effective April 1, 2019. Tyler will also remain as president. Edward Mueller, currently
September 14, 2018 by Chain Drug Review
Dominic Caruso, John Hammergren, McKesson Corp.
Leading Headlines, Pharmacy, Retail News
SAN FRANCISCO — McKesson Corp. announced that its board of directors has elected Dominic Caruso as a new independent director, effective September 12, 2018. With the election of Dominic Caruso, McKesson’s board of directors increases from eight to nine members, eight of whom are independent. “Dominic’s three decades of global financial and operational experience, leadership,
January 1, 2018 by Bill Schiffner
Britt Vitalone, Chris Dimos, Cigna, Cigna Pharmacy, Health Mart, James Beer, John Hammergren, McKesson, McKesson U.S. Pharmaceutical, Steve Courtman
2018, Issue 01-01-2018, Issues, News
SAN FRANCISCO — McKesson Corp. announced two key personnel moves, including the promotion of Chris Dimos to president of retail solutions for McKesson U.S. Pharmaceutical and Specialty Health. Dimos will now oversee the Health Mart pharmacy network, taking over from Steve Courtman, who left the company to join health insurer Cigna as senior vice president
December 11, 2017 by Bill Schiffner
John Hammergren, McKesson, Paul Julian
2017, Issue 12-11-2017, Issues, News
SAN FRANCISCO — Paul Julian, executive vice president and group president at McKesson Corp., is slated to retire at the end of the year. Julian currently has senior operating responsibility for McKesson’s domestic and international Distribution Solutions businesses, including pharmaceutical distribution, medical-surgical distribution, specialty health and retail pharmacy systems and automation. As president of McKesson
November 20, 2017 by Geoff Walden and Chain Drug Review
CVS Health, John Hammergren, McKesson, RxCrossroads
2017, Issue 11-20-2017, Issues, News
SAN FRANCISCO — McKesson Corp. has agreed to buy RxCrossroads, a provider of tailored services to pharmaceutical and biotechnology manufacturers, from CVS Health. The deal, expected to close early next year, is valued at $735 million, or about $635 million net of the present value of incremental cash tax benefits. It will be funded by
November 7, 2017 by Bill Schiffner
CVS Health, John Hammergren, McKesson, McKesson Specialty Health, RxCrossroads
Business, Leading Headlines, Pharmacy, Supplier News
SAN FRANCISCO — McKesson Corp. announced late Monday that it had signed a definitive agreement to purchase RxCrossroads, a provider of tailored services to pharmaceutical and biotechnology manufacturers, from CVS Health. The transaction is valued at $735 million, or approximately $635 million net of the present value ofincremental cash tax benefits, and will be funded by
October 26, 2017 by Chain Drug Review
Commission on Combating Drug Addiction and the Opioid Epidemic, CVS Health, Healthcare Distribution Alliance, John Gray, John Hammergren, Larry Merlo, McKesson, Melania Trump, opioid abuse crisis, opioid abuse epidemic, President Donald Trump, President's Commission on Combating Drug Addiction and the Opioid Crisis, Stefano Pessina, video, Walgreens Boots Alliance
Leading Headlines, Pharmacy, Retail News, Videos
WASHINGTON — Following through on pledge made this summer, President Donald Trump has formally declared the nation’s growing opioid abuse epidemic as a public health emergency. In a press conference at the White House on Thursday, the president and First Lady Melania Trump announced the action, which has drawn plaudits from public officials and pharmacy
October 23, 2017 by Chain Drug Review
Commission on Combating Drug Addiction and the Opioid Epidemic, John Hammergren, McKesson, opioid abuse crisis, opioid epidemic, President Donald Trump
Leading Headlines, Pharmacy, Supplier News
SAN FRANCISCO — McKesson Corp. chairman and chief executive officer John Hammergren has endorsed President Donald Trump’s plan to designate the opioid abuse crisis as a national emergency. Trump this week is expected to formally declare the growing misuse and abuse of narcotic painkillers as a national emergency after saying this summer that he planned
September 1, 2017 by Chain Drug Review
Chris Smith, Direct Relief, Hurricane Harvey, Jim Marshall, John Hammergren, McKesson, McKesson Foundation, Thomas Tighe, World Vision
Featured Articles, Leading Headlines, Supplier News
SAN FRANCISCO — McKesson Corp. has boosted its Hurricane Harvey relief donations to more than $300,000 in support of recovery efforts in the inundated Houston area. McKesson and the McKesson Foundation late Thursday announced $100,000 cash donation to nonprofit Direct Relief and $150,000 in-kind donation of medical supplies to World Vision. The two organizations will
January 30, 2017 by Chain Drug Review
CoverMyMeds, drug prior authorization, electronic prior authorization, John Hammergren, Matt Scantland, McKesson, Sam Rajan
Business, Pharmacy, Supplier News, Technology
SAN FRANCISCO — McKesson Corp. is bolstering its pharmacy technology services with its $1.1 billion deal to acquire CoverMyMeds LLC from private equity firm Francisco Partners. Columbus, Ohio-based CoverMyMeds provides the nation’s largest electronic prior authorization (ePA) platform for medications. The company said its software suite automates the drug prior authorization process for more than
January 18, 2017 by Chain Drug Review
AmerisourceBergen, Cardinal Health, Controlled Substances Act, DEA, Department of Justice, distribution of opioid medications, DOJ, Drug Enforcement Administration, John Hammergren, McKesson, prescription drug abuse, prescription drug diversion
Leading Headlines, Pharmacy, Supplier News
SAN FRANCISCO — McKesson Corp. has agreed to pay $150 million in a settlement with the Drug Enforcement Administration (DEA) and Department of Justice (DOJ) involving its monitoring and reporting of suspicious controlled substance orders. McKesson said late Tuesday that under the administrative and civil settlements the DEA will suspend the company’s DEA registrations to